Stockreport

Relmada Therapeutics Acquires Potential Therapy for Tourette Syndrome from Asarina Pharma AB [Yahoo! Finance]

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com
PDF 6 min read In This Article RLMD Relmada Therapeutics Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and othe [Read more]